We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of HZNP yet.

HZNP Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q1 2026, worth a combined $116 — unchanged from a quarter earlier.

Fund positioning in HZNP was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $116 of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.